Search filters

List of works by André Lacour

A one-degree-of-freedom test for supra-multiplicativity of SNP effects

scientific article

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

scientific article

Analysis of the progression of systolic blood pressure using imputation of missing phenotype values

scientific article published on 17 June 2014

Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene

scientific article

Gene set enrichment analysis and expression pattern exploration implicate an involvement of neurodevelopmental processes in bipolar disorder

scientific article

Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder

scientific article

Genome-wide association study reveals two new risk loci for bipolar disorder

scientific article (publication date: 11 March 2014)

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

scientific article

Haplotype synthesis analysis reveals functional variants underlying known genome-wide associated susceptibility loci

scientific article published on 21 March 2016

Identification of shared risk loci and pathways for bipolar disorder and schizophrenia

scientific article

Integrated Genome-Wide Pathway Association Analysis with INTERSNP

article

METAINTER: meta-analysis of multiple regression models in genome-wide association studies

scientific article published on 23 September 2014

Novel genetic matching methods for handling population stratification in genome-wide association studies

scientific article published on 14 March 2015

PLD3 in non-familial Alzheimer's disease

scientific article published in April 2015

Quick, "imputation-free" meta-analysis with proxy-SNPs

scientific article

Rare variant testing of imputed data: an analysis pipeline typified

scientific article

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

scientific article